Nsaid enteritis: 5 Questions Worth Asking Your Gastroenterologist

Bring questions that change the care plan

NSAID enteritis is small-bowel injury associated with nonsteroidal anti-inflammatory drugs such as ibuprofen, naproxen, or aspirin. It may cause erosions, ulcers, occult bleeding, and occasionally diaphragm-like narrowing. Bring the questions to the visit with reports and ask for a named result owner. This article moves from “Could my complete medicine list explain the finding?” toward “What pain medicine can I use instead?” See the topic overview for context.

Small-bowel injury differs from gastric injury; PPIs are not reliable small-bowel protection. Crohn disease and infection may look similar on capsule. The practical question is: Which answer will change the treatment decision?

Do not abruptly stop prescribed aspirin or antiplatelet therapy without the responsible clinician. A PPI is not a reliable cure for distal small-bowel erosions. Read the diagnosis pathway for how the next result might be obtained. GastroDoxs GutSignal Decode™ is the supplied education pathway label.

Capsule and imaging studies describe NSAID-related small-bowel injury and diaphragm-like strictures. Acid suppression often protects the upper gut but does not reliably prevent small-bowel injury. The Original capsule study — Long-term NSAID small-bowel injury provides the main clinical basis; it must be applied to an actual biopsy, laboratory value, or imaging report.

Bring a full OTC and prescription NSAID or aspirin history, cardiovascular indication, CBC and ferritin trends, stool color, capsule or enterography report, and prior Crohn or infection evaluation. The Clinical imaging — NSAID enteropathy and diaphragm strictures adds detail about a complementary test or treatment choice. Date each result and interpret it with the symptom pattern.

Capsule images of small-bowel ulcers can resemble Crohn disease or infection. The exact drug, dose, timing, blood counts, imaging, and sometimes biopsy guide attribution. A suspected narrowing changes capsule safety. “Is a capsule safe for me?” may alter the interpretation. Ask what explanation remains if that clue is absent.

Illustrative composite: Iron deficiency after long-term pain medicine use prompts small-bowel evaluation; the team distinguishes drug injury from Crohn and checks for narrowing. This doctor questions discussion moves from “Could my complete medicine list explain the finding?” to “What pain medicine can I use instead?” This is not a real patient record.

Reconcile NSAID and aspirin exposures with small-bowel findings, coordinate medicine changes, assess anemia, and investigate narrowing safely. The decision follows verified findings, not a count of the points above.

For a related clinical route, see crohn disease overview. The original report and current condition can change what happens next.

Start with “Could my complete medicine list explain the finding?” Record its date or context and one objective result that would support or weaken the working explanation.

Consider “Is a capsule safe for me?” alongside “What pain medicine can I use instead?” Ask which changes the immediate care setting, the diagnostic test, or follow-up. The overview helps frame this discussion.

Reconcile NSAID and aspirin exposures with small-bowel findings, coordinate medicine changes, assess anemia, and investigate narrowing safely. The ESGE — Small-bowel capsule and enteroscopy guideline provides additional source detail; its patient population may differ from yours.

Settle who reviews the pending result and what requires earlier contact. Monitor NSAID use, hemoglobin and ferritin, stool bleeding, pain, and signs of a stricture.

For a stable presentation, use the original evidence and result-directed action. Reconcile NSAID and aspirin exposures with small-bowel findings, coordinate medicine changes, assess anemia, and investigate narrowing safely.

If symptoms change, revise the timetable: Heavy or black tarry stool with weakness, fainting, severe pain with distension, repeated vomiting, or inability to pass gas warrants urgent assessment.

Coordinate reduction or alternatives for the offending NSAID with the prescriber, address anemia and confirmed complications, and choose imaging or enteroscopy based on bleeding and narrowing risk. The condition care overview connects this article with the available care overview.

The patient journey illustrates concern, tests, and follow-up. For this topic, monitor NSAID use, hemoglobin and ferritin, stool bleeding, pain, and signs of a stricture.

Request the next test or procedure date, who receives its result, and the change that would bring care forward. Keep the original report rather than only a portal summary.

Heavy or black tarry stool with weakness, fainting, severe pain with distension, repeated vomiting, or inability to pass gas warrants urgent assessment. Judge a serious new symptom by its current severity even if an older report was reassuring.

When seeking help, state onset, medicines, and the most recent result.

• Black tarry stool or heavy bleeding
• Fainting, chest pain, or weakness
• Severe pain with distension
• Repeated vomiting or inability to pass gas

• Keep the report and date relevant to “Could my complete medicine list explain the finding?”
• Ask: Which answer will change the treatment decision?
• Agree on a measure for NSAID use, hemoglobin and ferritin, stool bleeding, pain, and signs of a stricture.
• Record the result owner and follow-up date.
• Use the urgent threshold for NSAID enteritis if the pattern changes.